BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38698018)

  • 21. Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients.
    Doola R; Greer RM; Hurford R; Flatley C; Forbes JM; Todd AS; Joyce CJ; Sturgess DJ
    Clin Nutr; 2019 Aug; 38(4):1707-1712. PubMed ID: 30170779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU?
    Okabayashi T; Shima Y
    Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):190-9. PubMed ID: 24378668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Software-guided insulin dosing: tight glycemic control and decreased glycemic derangements in critically ill patients.
    Saur NM; Kongable GL; Holewinski S; O'Brien K; Nasraway SA
    Mayo Clin Proc; 2013 Sep; 88(9):920-9. PubMed ID: 24001484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
    Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
    Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial.
    Dubois J; Van Herpe T; van Hooijdonk RT; Wouters R; Coart D; Wouters P; Van Assche A; Veraghtert G; De Moor B; Wauters J; Wilmer A; Schultz MJ; Van den Berghe G; Mesotten D
    Crit Care; 2017 Aug; 21(1):212. PubMed ID: 28806982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose control and mortality in critically ill patients.
    Finney SJ; Zekveld C; Elia A; Evans TW
    JAMA; 2003 Oct; 290(15):2041-7. PubMed ID: 14559958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD006832. PubMed ID: 24477672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of intensive insulin therapy on the mortality of critically ill patients in intensive care unit: a meta-analysis].
    Li J; Li L; Ma B; Yang KH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):349-52. PubMed ID: 19570341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COMPARISON OF BASAL INSULIN REGIMENS ON GLYCEMIC VARIABILITY IN NONCRITICALLY ILL PATIENTS WITH TYPE 2 DIABETES.
    Haw JS; Farrokhi F; Smiley D; Peng L; Reyes D; Newton C; Pasquel FJ; Vellanki P; Umpierrez GE
    Endocr Pract; 2015 Dec; 21(12):1333-43. PubMed ID: 26307899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive insulin therapy versus conventional insulin therapy for critically ill trauma patients admitted to ICU.
    Aldawood AS; Tamim HM; Alsultan MA; Rishu AH; Arabi YM
    Middle East J Anaesthesiol; 2010 Jun; 20(5):659-66. PubMed ID: 20803853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
    Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moderate glycemic control safe in critically ill adult burn patients: A 15 year cohort study.
    Stoecklin P; Delodder F; Pantet O; Berger MM
    Burns; 2016 Feb; 42(1):63-70. PubMed ID: 26691869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes.
    Becker CD; Sabang RL; Nogueira Cordeiro MF; Hassan IF; Goldberg MD; Scurlock CS
    Am J Med; 2020 Oct; 133(10):e568-e574. PubMed ID: 32278843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tight Glycemic Control in Critically Ill Children.
    Agus MS; Wypij D; Hirshberg EL; Srinivasan V; Faustino EV; Luckett PM; Alexander JL; Asaro LA; Curley MA; Steil GM; Nadkarni VM;
    N Engl J Med; 2017 Feb; 376(8):729-741. PubMed ID: 28118549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose management in critically ill medical and surgical patients.
    Schiffner L
    Dimens Crit Care Nurs; 2014; 33(2):70-7. PubMed ID: 24496255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early versus late intravenous insulin administration in critically ill patients.
    Honiden S; Schultz A; Im SA; Nierman DM; Gong MN
    Intensive Care Med; 2008 May; 34(5):881-7. PubMed ID: 18180902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing.
    Fox MA; Perry MC; Liu-DeRyke X
    Pharmacotherapy; 2020 Mar; 40(3):186-190. PubMed ID: 31995840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control.
    Grey NJ; Perdrizet GA
    Endocr Pract; 2004; 10 Suppl 2():46-52. PubMed ID: 15251640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive insulin therapy in hospitalized patients: a systematic review.
    Kansagara D; Fu R; Freeman M; Wolf F; Helfand M
    Ann Intern Med; 2011 Feb; 154(4):268-82. PubMed ID: 21320942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of hyperglycemic control in pediatric intensive care.
    Macrae D; Grieve R; Allen E; Sadique Z; Morris K; Pappachan J; Parslow R; Tasker RC; Elbourne D;
    N Engl J Med; 2014 Jan; 370(2):107-18. PubMed ID: 24401049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.